全EXOME定序市場報告：2030 年趨勢、預測與競爭分析

全EXOME定序趨勢與預測

預計到 2030 年，全球全EXOME定序市場將達到 37 億美元，2024 年至 2030 年複合年成長率為 14.6%。該市場的主要促進因素是定序在科學技術中的應用不斷擴大、基因組和下一代定序技術的持續開拓以及對個人化醫療不斷成長的需求。全球全EXOME定序市場前景廣闊，臨床診斷、藥物發現和開發以及個人化醫療市場充滿機會。

按片段進行全EXOME定序

這項研究包括按產品、技術、應用、最終用途和地區對全球全EXOME序的預測。

全EXOME定序市場洞察

Lucintel 預測，消耗品將在預測期內達到最高成長。

在該市場中，藥物發現和市場開拓在預測期內仍將是最大的部分。

在預測期內，北美仍將是最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球全EXOME定序市場預計將達到 37 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球全EXOME定序市場預期複合年成長率為14.6%。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是這種測序在科學技術中的不斷擴大的應用、基因組和次世代定序技術的持續開拓以及對個性化醫療不斷成長的需求。

Q4.市場的主要細分市場是：

A4. 由於臨床診斷、藥物發現/開發和個人化醫療市場的機會，整個EXOME定序市場的未來性充滿希望。

Q5.市場的主要企業是：

A5. 主要的全EXOME定序公司是：

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• BGI
• PacBio
• Oxford Nanopore Technologies
• Azenta
• CD Genomics
• Novogene
• Eurofins Genomics

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計消耗品在預測期間內將出現最高成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 在預測期內，北美仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球全EXOME定序市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球全EXOME定序市場趨勢（2018-2023）與預測（2024-2030）
• 按產品分類的全球EXOME定序市場
  • 裝置
  • 消耗品
  • 服務
• 按技術分類的全球EXOME定序市場
  • 合成定定序
  • ION半導體定序
  • 其他
• 全球EXOME定序市場（按應用）
  • 臨床診斷
  • 藥物發現與開發
  • 個人化醫療
  • 其他
• 按最終用途分類的全球EXOME定序市場
  • 學術研究所
  • 醫院/診所
  • 製藥和生物技術公司
  • 其他

第4章 2018-2030年區域市場趨勢及預測分析

• 全球全EXOME定序市場（按地區）
• 北美全EXOME定序市場
• 歐洲全EXOME定序市場
• 亞太全EXOME定序市場
• 其他區域全EXOME定序市場

第5章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球全EXOME定序市場成長機會（按產品）
  • 全球全EXOME定序市場成長機會（依技術）
  • 全球全EXOME定序市場成長機會（按應用）
  • 全球全EXOME定序市場成長機會（依最終用途）
  • 按地區分類的全球全EXOME定序市場成長機會
• 全球全EXOME定序市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球全EXOME定序市場的產能
  • 全球全EXOME定序市場的併購與合資
  • 認證和許可

第7章主要企業概況

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• BGI
• PacBio
• Oxford Nanopore Technologies
• Azenta
• CD Genomics
• Novogene
• Eurofins Genomics

Whole Exome Sequencing Trends and Forecast

The future of the global whole exome sequencing market looks promising with opportunities in the clinical diagnostic, drug discovery & development, and personalized medicine markets. The global whole exome sequencing market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are growing application of this sequencing in science and technology, ongoing development in genomics and next-generation sequencing technologies, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Whole Exome Sequencing by Segment

The study includes a forecast for the global whole exome sequencing by product, technology, application, end use, and region.

Whole Exome Sequencing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

Whole Exome Sequencing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Sequencing by Synthesis
• ION Semiconductor Sequencing
• Others

Whole Exome Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Clinical Diagnostics
• Drug Discovery & Development
• Personalized Medicines
• Others

Whole Exome Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Whole Exome Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Whole Exome Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies whole exome sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whole exome sequencing companies profiled in this report include-

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• BGI
• PacBio
• Oxford Nanopore Technologies
• Azenta
• CD Genomics
• Novogene
• Eurofins Genomics

Whole Exome Sequencing Market Insights

Lucintel forecasts that consumable is expected to witness the highest growth over the forecast period.

Within this market, drug discovery & development will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Whole Exome Sequencing Market

Market Size Estimates: Whole exome sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Whole exome sequencing market size by various segments, such as by product, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Whole exome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, applications, end uses, and regions for the whole exome sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whole exome sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the whole exome sequencing market size?

Answer: The global whole exome sequencing market is expected to reach an estimated $3.7 billion by 2030.

Q2. What is the growth forecast for whole exome sequencing market?

Answer: The global whole exome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the whole exome sequencing market?

Answer: The major drivers for this market are growing application of this sequencing in science and technology, ongoing development in genomics and next-generation sequencing technologies, and rising demand for personalized medicine.

Q4. What are the major segments for whole exome sequencing market?

Answer: The future of the whole exome sequencing market looks promising with opportunities in the clinical diagnostic, drug discovery & development, and personalized medicine markets.

Q5. Who are the key whole exome sequencing market companies?

Answer: Some of the key whole exome sequencing companies are as follows:

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• BGI
• PacBio
• Oxford Nanopore Technologies
• Azenta
• CD Genomics
• Novogene
• Eurofins Genomics

Q6. Which whole exome sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that consumable is expected to witness the highest growth over the forecast period.

Q7. In whole exome sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the whole exome sequencing market by product (instruments, consumables, and services), technology (sequencing by synthesis, ion semiconductor sequencing, and others), application (clinical diagnostics, drug discovery & development, personalized medicines, and others), end use (academic & research institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Whole Exome Sequencing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Whole Exome Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Whole Exome Sequencing Market by Product
  • 3.3.1: Instruments
  • 3.3.2: Consumables
  • 3.3.3: Services
• 3.4: Global Whole Exome Sequencing Market by Technology
  • 3.4.1: Sequencing by Synthesis
  • 3.4.2: ION Semiconductor Sequencing
  • 3.4.3: Others
• 3.5: Global Whole Exome Sequencing Market by Application
  • 3.5.1: Clinical Diagnostics
  • 3.5.2: Drug Discovery & Development
  • 3.5.3: Personalized Medicines
  • 3.5.4: Others
• 3.6: Global Whole Exome Sequencing Market by End Use
  • 3.6.1: Academic & Research Institutes
  • 3.6.2: Hospitals & Clinics
  • 3.6.3: Pharmaceutical & Biotechnology Companies
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Whole Exome Sequencing Market by Region
• 4.2: North American Whole Exome Sequencing Market
  • 4.2.1: North American Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
  • 4.2.2: North American Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
• 4.3: European Whole Exome Sequencing Market
  • 4.3.1: European Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
  • 4.3.2: European Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
• 4.4: APAC Whole Exome Sequencing Market
  • 4.4.1: APAC Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
  • 4.4.2: APAC Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
• 4.5: ROW Whole Exome Sequencing Market
  • 4.5.1: ROW Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
  • 4.5.2: ROW Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Whole Exome Sequencing Market by Product
  • 6.1.2: Growth Opportunities for the Global Whole Exome Sequencing Market by Technology
  • 6.1.3: Growth Opportunities for the Global Whole Exome Sequencing Market by Application
  • 6.1.4: Growth Opportunities for the Global Whole Exome Sequencing Market by End Use
  • 6.1.5: Growth Opportunities for the Global Whole Exome Sequencing Market by Region
• 6.2: Emerging Trends in the Global Whole Exome Sequencing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Whole Exome Sequencing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Whole Exome Sequencing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Illumina
• 7.3: Agilent Technologies
• 7.4: BGI
• 7.5: PacBio
• 7.6: Oxford Nanopore Technologies
• 7.7: Azenta
• 7.8: CD Genomics
• 7.9: Novogene
• 7.10: Eurofins Genomics